A detailed history of Nwam LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nwam LLC holds 4,992 shares of VRTX stock, worth $2.51 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
4,992
Previous 4,860 2.72%
Holding current value
$2.51 Million
Previous $2.03 Million 15.16%
% of portfolio
0.69%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$392.81 - $485.53 $51,850 - $64,089
132 Added 2.72%
4,992 $2.34 Million
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $815 - $892
-2 Reduced 0.04%
4,860 $2.03 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $3,773 - $4,517
11 Added 0.23%
4,862 $1.98 Million
Q3 2023

Oct 31, 2023

SELL
$338.18 - $362.46 $3,381 - $3,624
-10 Reduced 0.21%
4,851 $1.69 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $3,773 - $4,222
-12 Reduced 0.25%
4,861 $1.71 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $21,242 - $24,232
-75 Reduced 1.52%
4,873 $1.54 Million
Q4 2022

Feb 07, 2023

BUY
$285.76 - $321.48 $8,572 - $9,644
30 Added 0.61%
4,948 $1.43 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $29,025 - $32,386
106 Added 2.2%
4,918 $1.42 Million
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $225,796 - $281,140
-961 Reduced 16.65%
4,812 $1.39 Million
Q1 2022

May 12, 2022

SELL
$221.42 - $260.97 $221 - $260
-1 Reduced 0.02%
5,773 $1.51 Million
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $591,036 - $746,099
3,339 Added 137.13%
5,774 $1.27 Million
Q3 2021

Nov 03, 2021

BUY
$181.39 - $202.99 $441,684 - $494,280
2,435 New
2,435 $442,000
Q3 2020

Oct 16, 2020

SELL
$255.65 - $303.1 $298,854 - $354,323
-1,169 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$225.48 - $295.8 $1,352 - $1,774
6 Added 0.52%
1,169 $339,000
Q1 2020

Apr 16, 2020

SELL
$199.77 - $247.81 $19,977 - $24,781
-100 Reduced 7.92%
1,163 $277,000
Q4 2019

Jan 23, 2020

BUY
$166.71 - $223.91 $210,554 - $282,798
1,263 New
1,263 $277,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.